Stress Echocardiography Report

Study Information

Patient: [name, MRN, DOB, sex]

Height/Weight: [height, weight]

Date of Study: [date]

Ordering Clinician: [name]

Sonographer: [name/initials]

Interpreting Physician: [name]

Comparison: [date of prior stress echo / No prior study available]

Indication

[Reason for testing and clinical question] (Include concise clinical context affecting interpretation such as symptoms, known coronary disease, or prior revascularization. Keep to one to two sentences.)

Stress Protocol and Performance

Stress Modality: [exercise treadmill / exercise bicycle / pharmacologic with agent]

Protocol: [protocol name]

Contrast: [agent used and indication / None]

Baseline:

• Heart rate: [value bpm]
• Blood pressure: [systolic/diastolic mmHg]
• Rhythm: [sinus / atrial fibrillation / paced / other]
• Symptoms: [none / description]
• Baseline ECG: [normal / abnormalities described]

Peak Stress:

• Exercise parameters (if applicable): [total time, stage achieved, METs]
• Pharmacologic parameters (if applicable): [agent, max dose, atropine use]
• Peak heart rate: [value bpm] ([percent]% predicted)
• Peak blood pressure: [systolic/diastolic mmHg]
• Reason for termination: [fatigue / dyspnea / chest pain / achieved target / protocol completion / other]
• Symptoms during stress: [none / description]

Stress ECG:

• ST-segment changes: [none observed / description including magnitude, leads, timing]
• Arrhythmias: [none observed / description]

Adequacy of Stress: [Target heart rate achieved / Not achieved]. [Workload adequate for diagnostic purposes / Suboptimal stress—reduced sensitivity for ischemia detection].

Adequacy of Imaging: [Good / Fair / Limited] overall image quality. Segments not adequately visualized: [specific segments / none]. (If contrast used, note effect on endocardial visualization.)

Findings

Rest:

• LV size: [normal / mildly dilated / moderately dilated / severely dilated]
• Global LV systolic function: [normal / mildly reduced / moderately reduced / severely reduced]; EF [value% or range]
• Regional wall motion at rest: [normal / abnormal—specify segments and severity] (Document any segments not visualized.)
• RV size and function: [brief summary]
• Relevant valvular or structural findings: [summary / none]

Stress Wall Motion: [Normal—no inducible wall motion abnormalities / Abnormal—details below]

• (If abnormal, for each region document: location by wall/segments, extent as number of segments, severity, temporal pattern including onset stage and persistence into recovery, and whether new/worsening versus fixed.)

Global LV Response:

• EF response: [normal augmentation / blunted / decreased]
• Cavity size response: [normal decrease / unchanged / increased]
• Stress-induced LV dilatation: [present / absent]

Coronary Territory Correlation: [Suggestive of LAD / LCx / RCA / multiterritory distribution—territory assignment is approximate / Not applicable—normal study]

High-Risk Features: [Multi-territory involvement / stress-induced cavity dilatation / fall in EF / extensive ischemia burden / early ischemia at low workload / severe arrhythmias / hemodynamic instability / No high-risk features identified] (List all that apply.)

Impression

Diagnostic Conclusion: [Normal stress echocardiogram / Abnormal—inducible ischemia / Abnormal—fixed wall motion abnormality / Mixed ischemia and scar / Equivocal or nondiagnostic with reason]

(If abnormal, summarize location, extent, severity, stage of onset, and global LV response in one to two sentences. Restate any adequacy limitations and impact on diagnostic confidence. If stress was inadequate and no ischemia detected, explicitly state reduced sensitivity and avoid labeling the study as definitively negative.)

Recommendations: [Follow-up testing or clinical actions / None] (Include only if clinically necessary for nondiagnostic or discordant results.)

Critical Results Communication: [Communicated to recipient, by whom, date/time / Not applicable]

Electronically signed by: [interpreting physician name and date]